ArticleBlood cancer journal2025

Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.

Sonja Wurm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.